50+ Over 50 active research collaborations with leading global institutions. 92% of our treatments in late-stage trials show improved efficacy based on real-world patient data. 10 million Our therapies have reached over 10 million patients in 40+ countries. Innovation That Transforms Lives Innovative Research Leveraging advanced biotechnology, AI-driven drug discovery, and precision medicine to develop groundbreaking treatments. Collaborative Partnerships Working with top research institutions, healthcare providers, and regulatory bodies to drive medical advancements. Data-Driven Development Utilizing real-world evidence and clinical insights to refine our therapies and maximize patient outcomes.